Literature DB >> 9438810

Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.

J S Fischgrund1, S B James, M C Chabot, R Hankin, H N Herkowitz, J M Wozney, A Shirkhoda.   

Abstract

This study evaluated the use of recombinant human bone morphogenetic protein (rhBMP-2) with various types of carrier media, and the effect of rhBMP-2 as an adjunct to autogenous iliac crest bone graft in the canine spinal fusion model. BMP induces mesenchymal cells to differentiate into cartilage and bone. The recent availability of rhBMP-2 has created the opportunity to evaluate this material's properties in augmenting autogenous bone graft in spinal fusion. Currently, the most appropriate type of carrier media for rhBMP-2 is undetermined. Bilateral intertransverse spinal fusions were performed on six canine lumbar spines at L1-L2, L3-L4, and L5-L6, using autogenous posterior iliac crest bone graft at each level, creating a total of 18 segmental fusion sites. All 18 sites were then randomly assigned to one of six fusion methods: autogenous bone graft (ABG) alone, ABG + rhBMP-2, ABG + collagen (Helistat) "sandwich" + rhBMP-2, ABG + collagen (Helistat) morsels + rhBMP-2, ABG + polylactic/glycolic acid sponge (PLGA) sandwich + rhBMP-2, and ABG + open-pore polylactic acid morsels + rhBMP-2. Each material was evaluated for ease of handling and application at the index surgery. The animals underwent computed tomography (CT) scanning of the lumbar fusion sites after 8 weeks. Volumetric measurements of total fusion mass at each level were performed using two-dimensional CT scan slices and a volumetric program supplied by the Siemens Medical System. The animals were killed after imaging studies. The lumbar spine fusion sites were evaluated for integrity of the fusion mass, both visually and with manual mechanical stressing. Crossover of the fusion mass to adjoining levels was also evaluated. Histologic evaluation of all fusion sites was performed. The addition of rhBMP-2 significantly increased bone graft volume as noted on CT scan. Carrier that could be mixed with morselized bone graft offered easier handling and application and all spine segments fused. Polylactic/glycolic acid (PLGA) sites were associated with a greater incidence of voids within the fusion mass. No significant difference in carrier media for rhBMP-2 could be determined. However, PLGA was associated with a higher rate of fusion mass void formation. rhBMP-2, when added to autograft, significantly increased the volume and the maturity of the resulting fusion mass.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438810

Source DB:  PubMed          Journal:  J Spinal Disord        ISSN: 0895-0385


  8 in total

1.  [Biodegradable cage. Osteointegration in spondylodesis of the sheep cervical spine].

Authors:  R Pflugmacher; T Eindorf; M Scholz; S Gumnior; C Krall; P Schleicher; N P Haas; F Kandziora
Journal:  Chirurg       Date:  2004-10       Impact factor: 0.955

2.  Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model.

Authors:  F Kandziora; R Pflugmacher; M Scholz; J Schäfer; G Schollmeier; G Schmidmaier; G Duda; M Raschke; N P Haas
Journal:  Eur Spine J       Date:  2002-11-08       Impact factor: 3.134

3.  Bone morphogenic proteins: applications in spinal surgery.

Authors:  Gerard K Jeong; Harvinder S Sandhu; James Farmer
Journal:  HSS J       Date:  2005-09

4.  Cyst-Like Osteolytic Formations in Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Augmented Sheep Spinal Fusion.

Authors:  Hsin Chuan Pan; Soonchul Lee; Kang Ting; Jia Shen; Chenchao Wang; Alan Nguyen; Emily A Berthiaume; Janette N Zara; A Simon Turner; Howard B Seim; Jin Hee Kwak; Xinli Zhang; Chia Soo
Journal:  Am J Pathol       Date:  2017-05-11       Impact factor: 4.307

5.  Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects.

Authors:  Yasuji Harada; Takamasa Itoi; Shigeyuki Wakitani; Hiroyuki Irie; Michiko Sakamoto; Dongwei Zhao; Yoshinori Nezu; Takuya Yogo; Yasushi Hara; Masahiro Tagawa
Journal:  J Bone Miner Metab       Date:  2011-11-02       Impact factor: 2.626

6.  Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study.

Authors:  Yoshito Katayama; Yukihiro Matsuyama; Hisatake Yoshihara; Yoshihito Sakai; Hiroshi Nakamura; Shiro Imagama; Zenya Ito; Norimitsu Wakao; Mitsuhiro Kamiya; Yasutsugu Yukawa; Tokumi Kanemura; Koji Sato; Hisashi Iwata; Naoki Ishiguro
Journal:  Int Orthop       Date:  2008-06-26       Impact factor: 3.075

7.  Compressed homologous cancellous bone and bone morphogenetic protein (BMP)-7 or bone marrow accelerate healing of long-bone critical defects.

Authors:  T Djapic; V Kusec; M Jelic; S Vukicevic; M Pecina
Journal:  Int Orthop       Date:  2003-08-26       Impact factor: 3.075

8.  Escherichia coli-derived recombinant human bone morphogenetic protein-2 combined with bone marrow-derived mesenchymal stromal cells improves bone regeneration in canine segmental ulnar defects.

Authors:  Takamasa Itoi; Yasuji Harada; Hiroyuki Irie; Michiko Sakamoto; Katsutoshi Tamura; Takuya Yogo; Satoshi Soeta; Hajime Amasaki; Yasushi Hara; Masahiro Tagawa
Journal:  BMC Vet Res       Date:  2016-09-13       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.